Scandidos
1,67 SEK +0,6%Vær den første som følger denne virksomhed
Scandidos are active in medical technology. The company provides products and systems for quality assurance of advanced radiation therapy against cancer. The systems analyze the radiation dose before and during ongoing radiation treatment. The company was founded in 2002 and the first product was launched in 2006. Since its inception, Scandidos has delivered products to radiation therapy clinics on a global level. The head office is located in Uppsala.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
SDOS
Daglig lav / høj pris
1,64 / 1,69
SEK
Markedsværdi
95,21 mio. SEK
Aktieomsætning
31,56 t SEK
Volumen
19 t
Seneste videoer
Finanskalender
Delårsrapport
18.09.2024
Generalforsamling
23.10.2024
Delårsrapport
17.12.2024
Delårsrapport
12.03.2025
Årsrapport
18.06.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Spore Invest AB | 29,5 % | 29,5 % |
Commerzbank AG, W8IMY - IBA Dosimetry | 10,1 % | 10,1 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
ScandiDos receives orders worth €478 000 from China
ScandiDos AB changes Certified Adviser and liquidity provider to Carnegie Investment Bank AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
ScandiDos achieves EU Medical Device Regulation certification for the Delta4 Phantom+ product line
ScandiDos receives orders worth €290 000 from China
ScandiDos and IBA Dosimetry deepen strategic alliance!
ScandiDos receives an order worth €263 000 from China
![Scandidos, Capital Markets Day, 2023](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/2d00f0cf-eafa-44dd-9af9-0c8b89ea0584.png)